Successful perioperative management of factor X deficiency associated with primary amyloidosis

Journal of Gastrointestinal Surgery

Volumn 8, Issue 3, 2004, Pages 358-362

  Takabe, Kazuaki ^a   Holman, Peter R ^b   Herbst, Kenneth D ^b   Glass, Catherine A ^b   Bouvet, Michael ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amyloidosis; Coagulopathy; Factor X; Hemorrhage; Operation

Indexed keywords

BLOOD CLOTTING FACTOR 9 COMPLEX; DESMOPRESSIN; FRESH FROZEN PLASMA; MELPHALAN; PREDNISOLONE; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADENOMA; ADULT; AMYLOIDOSIS; ANAMNESIS; ARTICLE; BLEEDING; BLOOD CLOTTING FACTOR 10 DEFICIENCY; CASE REPORT; CRYOPRECIPITATE; DISSEMINATED INTRAVASCULAR CLOTTING; HEMICOLECTOMY; HUMAN; MALE; PERIOPERATIVE PERIOD; PEROPERATIVE CARE; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE;

AMYLOIDOSIS; BLOOD COAGULATION FACTORS; COLECTOMY; FACTOR VIIA; FACTOR X DEFICIENCY; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS;

EID: 1542719194     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gassur.2003.10.014     Document Type: Article

References (29)

1. Choufani E.B., Sanchorawala V., Ernst T., Quillen K., Skinner M., Wright D.G., Seldin D.C. Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: Incidence, bleeding manifestations, and response to high-dose chemotherapy. Blood. 97:2001;1885-1887.
2. Mumford A.D., O'Donnell J., Gillmore J.D., Manning R.A., Hawkins P.N., Laffan M. Bleeding symptoms and coagulation abnormalities in 337 patients with AL-amyloidosis. Br J Haematol. 110:2000;454-460.
3. Sanchorawala V., Wright D.G., Seldin D.C., Dember L.M., Finn K., Falk R.H., Berk J., Quillen K., Skinner M. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis. Bone Marrow Transplant. 28:2001;637-642.
4. Greipp P.R., Kyle R.A., Bowie E.J. Factor-X deficiency in amyloidosis: A critical review. Am J Hematol. 11:1981;443-450.
5. Yood R.A., Skinner M., Rubinow A., Talarico L., Cohen A.S. Bleeding manifestations in 100 patients with amyloidosis. JAMA. 249:1983;1322-1324.
6. Dave S.P., Greenstein A.J., Sachar D.B., Harpaz N., Aledort L. Bleeding diathesis in amyloidosis with renal insufficiency associated with Crohn's disease: Response to desmopressin. Am J Gastroenterol. 97:2002;187-189.
7. Furie B., Voo L., McAdam K.P., Furie B.C. Mechanism of factor X deficiency in systemic amyloidosis. N Engl J Med. 304:1981;827-830.
8. Furie B., Greene E., Furie B.C. Syndrome of acquired factor X deficiency and systemic amyloidosis in vivo studies of the metabolic fate of factor X. N Engl J Med. 297:1977;81-85.
9. Aronson D.L. Factor IX complex. Semin Thromb Hemost. 6:1979;28-43.
10. Kasper C.K. Postoperative thromboses in hemophilia B. N Engl J Med. 289:1973;160.
11. Steinberg M.H., Breiling B.J. Vascular lesions in hemophilia B. N Engl J Med. 289:1973;592.
12. Chistolini A., Mazzucconi M.G., Tirindelli M.C., La Verde G., Ferrari A., Mandelli F. Disseminated intravascular coagulation and myocardial infarction in a haemophilia B patient during therapy with prothrombin complex concentrates. Acta Haematol. 83:1990;163-165.
13. Chavin S.I., Siegel D.M., Rocco T.A. Jr., Olson J.P. Acute myocardial infarction during treatment with an activated prothrombin complex concentrate in a patient with factor VIII deficiency and a factor VIII inhibitor. Am J Med. 85:1988;245-249.
14. Boggio L., Green D. Recombinant human factor VIIa in the management of amyloid-associated factor X deficiency. Br J Haematol. 112:2001;1074-1075.
15. Gertz M.A., Lacy M.Q., Dispenzieri A. Amyloidosis: Recognition, confirmation, prognosis, and therapy. Mayo Clin Proc. 74:1999;490-494.
16. Kyle R.A., Gertz M.A. Primary systemic amyloidosis: Clinical and laboratory features in 474 cases. Semin Hematol. 32:1995;45-59.
17. Thaler W., Schatzer G., Eder P., Fichtel G. Amyloidosis - An unusual case of recurrent intestinal bleeding and sigmoid perforation: Case report with review of the literature. Int J Colorectal Dis. 14:1999;297-299.
18. Usui M., Matsuda S., Suzuki H., Hirata K., Ogura Y., Shiraishi T. Gastric amyloidosis with massive bleeding requiring emergency surgery. J Gastroenterol. 35:2000;924-928.
19. Chang S.S., Lu C.L., Tsay S.H., Chang F.Y., Lee S.D. Amyloidosis-induced gastrointestinal bleeding in a patient with multiple myeloma. J Clin Gastroenterol. 32:2001;161-163.
20. Bohrer H., Waldherr R., Martin E., Linke R.P., Lin J., Ziegler R., Ritz E., Nawroth P.P. Splenectomy in an uraemic patient with acquired factor X deficiency due to AL amyloidosis. Nephrol Dial Transplant. 13:1998;190-193.
21. Greipp P.R., Kyle R.A., Bowie E.J. Factor X deficiency in primary amyloidosis: Resolution after splenectomy. N Engl J Med. 301:1979;1050-1051.
22. Uprichard J., Perry D.J. Factor X deficiency. Blood Rev. 16:2002;97-110.
23. Knight R.D., Barr C.F., Alving B.M. Replacement therapy for congenital factor X deficiency. Transfusion. 25:1985;78-80.
24. Bernhardt B., Valletta M., Brook J., Lejnieks I. Amyloidosis with factor X deficiency. Am J Med Sci. 264:1972;411-414.
25. Zeitler K.D., Blatt P.M. Amyloidosis and factor X deficiency. South Med J. 75:1982;306-308. 312.
26. Galbraith P.A., Sharma N., Parker W.L., Kilgour J.M. Acquired factor X deficiency. Altered plasma antithrombin activity and association with amyloidosis. JAMA. 230:1974;1658-1660.
27. Hedner U. Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa. Thromb Haemost. 82:1999;531-539.
28. Monroe D.M., Hoffman M., Oliver J.A., Roberts H.R. Platelet activity of high-dose factor VIIa is independent of tissue factor. Br J Haematol. 99:1997;542-547.
29. Kumar S., Dispenzieri A., Lacy M.Q., Litzow M.R., Gertz M.A. High incidence of gastrointestinal tract bleeding after autologous stem cell transplant for primary systemic amyloidosis. Bone Marrow Transplant. 28:2001;381-385.